SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesmarket

VIMIAN (VIMIAN) News

Follow VIMIAN (VIMIAN) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 5 public stories across 4 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol VIMIAN Asset market Sector Markets 90 days 5 Updated Oct 22, 2026, 05:54 AM UTC Open live news feed
M Vimian Q3 Revenue Rises 15%, Beats Estimates EQUITY | Oct 22, 2026, 05:54 AM UTC M Vimian Q3 Revenue Rises 15% to €120.3M; Adjusted EBITA €29.2M Vimian Group reported 11% organic revenue growth and adjusted EBITA at a 24.3% margin, up 14% year over year. After quarter-end, it signed the acquisition of Norfolk Medical Products. EQUITY | Oct 22, 2026, 05:45 AM UTC M Vimian Group to Buy Norfolk Medical Products in US MNA | Oct 21, 2026, 07:06 AM UTC L Change in the number of shares and votes in Vimian Change in the number of shares and votes in Vimian EQUITY | Aug 31, 2026, 03:30 PM UTC L Vimian Group appoints Hans Lord Skarplöth Head of Specialty Pharma Vimian Group AB (publ) appoints Hans Lord Skarplöth as Head of Specialty Pharma and a member of the Vimian Group management team. EQUITY | Aug 27, 2026, 05:30 AM UTC